Bharat Biotech International Limited is an Indian biotechnology company headquartered in Hyderabad, India engaged in thedrug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products. Read More
Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said that they are waiting for approval from the Drugs Controller General of India (DCGI) for the COVID-19 vaccine for children. ...
As India on Thursday crossed 100 crore COVID-19 vaccination, Bharat Biotech's Chairman and Managing Director Dr Krishna Ella said that the firm is proud to have contributed to this 'historic landmark'. ...
Zydus Cadila's vaccine - ZyCoV-D is the first indigenously manufactured needle-free Covid-19 vaccine which is approved for children aged above 12 for emergency use in the country. Earlier, the Subject Experts Committee (SEC) has also recommended the ...
World Health Organisation (WHO), which is reviewing the data provided by Bharat Biotech for Emergency Use Listing of COVID-19 vaccine Covaxin, said on Monday that it is "expecting one additional piece of information from the company today". ...
Vice President M Venkaiah Naidu called on the youth to be aware of India's ancient tradition and culture and uphold the national value of 'unity in diversity. ...
Dr Soumya Swaminathan, World Health Organisation (WHO) chief scientist on Sunday informed that WHO's technical advisory group will meet on October 26 to consider emergency use listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxi ...
The final approval for Bharat Biotech's Covaxin for children aged 2-18 years is under experts opinion and evaluation, stated Government sources on Thursday. ...
